Cellular Pharmacology of the Anti-Hepatitis B Virus Agent β-l-2′,3′-Didehydro-2′,3′-Dideoxy-N(4)-Hydroxycytidine: Relevance for Activation in HepG2 Cells

Similar Items

• Pharmacokinetics of the Antiviral Agent β-d-2′,3′-Didehydro-2′,3′-Dideoxy-5-Fluorocytidine in Rhesus Monkeys
  od: Ma, Li, i dr.
  Izdano: (1999)
• Anti-Hepatitis B Virus Activity and Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β-l(−)-5-Fluorocytidine
  od: Zhu, Yong-Lian, i dr.
  Izdano: (1998)
• Antiviral Activity of β-l-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus
  od: Le Guerhier, F., i dr.
  Izdano: (2001)
• Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model
  od: Le Guerhier, Franck, i dr.
  Izdano: (2000)
• In Vitro Selection and Analysis of Human Immunodeficiency Virus Type 1 Resistant to Derivatives of β-2′,3′-Didehydro-2′,3′-Dideoxy-5-Fluorocytidine
  od: Hammond, Jennifer L., i dr.
  Izdano: (2005)